Halozyme Therapeutics Cash from Financing (TTM) Trends

Halozyme Therapeutics Inc (HALO)

41.44 +0.58 (+1.42%) USD | NASDAQ | May 07, 12:13

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2002. Upgrade now.

Date	Value
December 31, 2023	-407.99M
September 30, 2023	-151.74M
June 30, 2023	-168.24M
March 31, 2023	197.13M
December 31, 2022	362.37M
September 30, 2022	200.03M
June 30, 2022	152.36M
March 31, 2022	-260.21M
December 31, 2021	77.86M
September 30, 2021	206.48M
June 30, 2021	222.69M
March 31, 2021	281.04M
December 31, 2020	-106.28M
September 30, 2020	131.54M
June 30, 2020	156.14M
March 31, 2020	126.32M
December 31, 2019	153.22M
September 30, 2019	-75.56M
June 30, 2019	-72.73M
March 31, 2019	-72.88M
December 31, 2018	-63.80M
September 30, 2018	-45.36M
June 30, 2018	-29.83M
March 31, 2018	122.39M
December 31, 2017	131.66M

Date	Value
September 30, 2017	131.85M
June 30, 2017	133.22M
March 31, 2017	2.793M
December 31, 2016	150.62M
September 30, 2016	152.07M
June 30, 2016	152.03M
March 31, 2016	150.39M
December 31, 2015	13.10M
September 30, 2015	13.84M
June 30, 2015	14.20M
March 31, 2015	11.62M
December 31, 2014	114.50M
September 30, 2014	135.10M
June 30, 2014	136.61M
March 31, 2014	135.35M
December 31, 2013	25.06M
September 30, 2013	31.74M
June 30, 2013	29.48M
March 31, 2013	29.44M
December 31, 2012	112.82M
September 30, 2012	83.68M
June 30, 2012	84.34M
March 31, 2012	86.00M
December 31, 2011	4.749M
September 30, 2011	5.263M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-407.99M

Minimum

Dec 2023

362.37M

Maximum

Dec 2022

53.92M

Average

131.54M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks